Myriad Genetics, Inc. (MYGN) EPS Estimated At $0.26, Northwestern (NWE) SI Increased By 12.58%

July 25, 2017 - By Adrian Mccoy

Northwestern Corporation (NYSE:NWE) had an increase of 12.58% in short interest. NWE’s SI was 1.28M shares in July as released by FINRA. Its up 12.58% from 1.14M shares previously. With 333,700 avg volume, 4 days are for Northwestern Corporation (NYSE:NWE)’s short sellers to cover NWE’s short positions. The SI to Northwestern Corporation’s float is 2.66%. About 50,305 shares traded. NorthWestern Corp (NYSE:NWE) has risen 6.36% since July 25, 2016 and is uptrending. It has underperformed by 10.34% the S&P500.

Analysts expect Myriad Genetics, Inc. (NASDAQ:MYGN) to report $0.26 EPS on August, 8.They anticipate $0.10 EPS change or 27.78% from last quarter’s $0.36 EPS. MYGN’s profit would be $17.74M giving it 22.97 P/E if the $0.26 EPS is correct. After having $0.27 EPS previously, Myriad Genetics, Inc.’s analysts see -3.70% EPS growth. About 169,957 shares traded. Myriad Genetics, Inc. (NASDAQ:MYGN) has declined 37.47% since July 25, 2016 and is downtrending. It has underperformed by 54.17% the S&P500.

Among 18 analysts covering Myriad Genetics (NASDAQ:MYGN), 2 have Buy rating, 5 Sell and 11 Hold. Therefore 11% are positive. Myriad Genetics had 36 analyst reports since July 21, 2015 according to SRatingsIntel. Ladenburg Thalmann upgraded the stock to “Neutral” rating in Wednesday, February 8 report. Avondale maintained the stock with “Market Outperform” rating in Wednesday, May 4 report. The rating was maintained by Mizuho with “Neutral” on Wednesday, November 4. The stock has “Overweight” rating by Piper Jaffray on Tuesday, September 15. The rating was maintained by Leerink Swann on Wednesday, May 4 with “Market Perform”. The stock has “Hold” rating by Piper Jaffray on Thursday, July 13. The company was maintained on Wednesday, August 10 by Morgan Stanley. As per Wednesday, August 10, the company rating was downgraded by Barclays Capital. Gabelli initiated it with “Buy” rating and $42 target in Tuesday, July 21 report. The rating was downgraded by PiperJaffray to “Neutral” on Wednesday, August 10.

Myriad Genetics, Inc. is a molecular diagnostic company. The company has market cap of $1.63 billion. The Firm is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. It has a 38.98 P/E ratio. The Firm operates through two divisions: diagnostics and other.

Since February 22, 2017, it had 1 buying transaction, and 0 insider sales for $111,930 activity. 6,000 shares valued at $111,930 were bought by HENDERSON JOHN T on Wednesday, February 22.

Investors sentiment increased to 1.1 in Q4 2016. Its up 0.13, from 0.97 in 2016Q3. It improved, as 31 investors sold Myriad Genetics, Inc. shares while 66 reduced holdings. 36 funds opened positions while 71 raised stakes. 77.40 million shares or 3.10% less from 79.87 million shares in 2016Q3 were reported. Frontier Mngmt Ltd Com holds 0.39% of its portfolio in Myriad Genetics, Inc. (NASDAQ:MYGN) for 3.03 million shares. Invesco accumulated 460,316 shares. Moreover, California State Teachers Retirement has 0% invested in Myriad Genetics, Inc. (NASDAQ:MYGN) for 139,171 shares. The New York-based Bnp Paribas Arbitrage has invested 0% in Myriad Genetics, Inc. (NASDAQ:MYGN). Schwab Charles Mngmt Inc holds 669,102 shares or 0.01% of its portfolio. Fisher Asset Ltd Limited Liability Company reported 0% stake. Jpmorgan Chase & Communications holds 6,773 shares. Moreover, Ubs Asset Mngmt Americas Incorporated has 0% invested in Myriad Genetics, Inc. (NASDAQ:MYGN) for 23,697 shares. Wells Fargo And Comm Mn reported 0% of its portfolio in Myriad Genetics, Inc. (NASDAQ:MYGN). Aqr Mngmt Limited Liability holds 0.01% or 360,626 shares. Blackrock Advsr Ltd accumulated 88,952 shares. Convergence Investment Partners Limited Liability Company reported 16,378 shares. Blackrock Japan Limited reported 378 shares. Dimensional Fund Limited Partnership, Texas-based fund reported 1.65 million shares. Albert D Mason has 16,132 shares for 0.23% of their portfolio.